Impact of continued administration of tolvaptan on cirrhotic patients with ascites

BACKGROUND: The vasopressin V2-receptor antagonist tolvaptan is used to treat cirrhotic patients with ascites. We investigated the outcome of long-term treatment. METHODS: This was a single-center retrospective study. Overall, 170 cirrhotic patients (95 males, median age 63 years) were enrolled and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kogiso, Tomomi, Sagawa, Takaomi, Kodama, Kazuhisa, Taniai, Makiko, Tokushige, Katsutoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299627/
https://www.ncbi.nlm.nih.gov/pubmed/30563565
http://dx.doi.org/10.1186/s40360-018-0277-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299627/
https://www.ncbi.nlm.nih.gov/pubmed/30563565
http://dx.doi.org/10.1186/s40360-018-0277-3

Ejemplares similares